用户名：

密码：

还没有陶术账户？去注册忘记密码

手机号码：

验证码：

还没有陶术账户？去注册忘记密码

手机号码：

验证码：

密码：

6~16个字符、区分大小写、必须包含字母和数字

确认密码：

手机号码：

验证码：

新密码：

6~16个字符、区分大小写、必须包含字母和数字

确认密码：

密码已经重置成功，快去使用新密码吧！
登录账号

记住密码忘记密码？

6~16个字符、区分大小写、必须包含字母和数字

6~16个字符、区分大小写、必须包含字母和数字

密码已经重置成功，快去使用新密码吧！登录账号

搜索结果

"1370023-80-5" 的搜索结果

Targets Recommended: p53 5-HT Receptor P450

目录号	产品详情		靶点
T70846	Deleobuvir sodium		Others
T70846	Deleobuvir sodium is the salt form of Deleobuvir, also known as BI207127, a non-nucleoside hepatitis C virus NS5B polymerase inhibitor for the treatment of hepatitis C. Deleobuvir was tested in combination regimens with pegylated interferon and ribavirin, and in interferon-free regimens with other direct-acting antiviral agents including faldaprevir. Deleobuvir showed that a triple combination of deleobuvir, faldaprevir, and ribavirin performed well in HCV genotype 1b patients. Efficacy fell below 50%, however, for dual regimens without ribavirin and for genotype 1a patients. In December 2013, deleobuvir was discontinued since recent findings from phase III trials did not suggest sufficient efficacy.		Others
T31369	Deleobuvir	BI207127,BI-207127,BI 207127,BI-207127NA	Others
T31369	Deleobuvir(BI207127) is an inhibitor of non-nucleoside hepatitis C virus NS5B polymerase for the treatment of hepatitis C.		Others